Skip to content

Short-Term Clinical and Patient-Reported Outcomes of Guided Bone Regeneration vs. Ribose Cross-Linked Collagen Scaffold for Posterior Implant-supported Single Crown: A Cross-Sectional Study

Short-Term Clinical and Patient-Reported Outcomes of Guided Bone Regeneration vs. Ribose Cross-Linked Collagen Scaffold for Posterior Implant-supported Single Crown: A Cross-Sectional Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20251102012
Enrollment
81
Registered
2025-11-02
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Patients with single tooth replacement with dental implant on posterior teeth area. 2. Patients with at least one premolar or molar ISSC, being restored for at least 6 months and with at least one inter-proximal contact to an adjacent natural tooth and one occluded tooth. 3. Healthy patients with age 20 year old and over Ribose cross-linked collagen scaffold, Conventional guided bone regeneration

Interventions

Patient with dental implant placement with Conventional guided bone regeneration using Xenoflex bone substituted with Ossix plus resorbable membrane) ,Patient with dental implant placement with Ribos
Other,Other,Other
CGBR group : conventional guided bone regeneration,RCCS group : Ribose cross-linked collagen scaffold ,Control group

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with single tooth replacement with dental implant on posterior teeth area. 2. Patients with at least one premolar or molar ISSC, being restored for at least 6 months and with at least one inter-proximal contact to an adjacent natural tooth and one occluded tooth. 3. CGBR group: patients who received conventional guided bone regeneration with Xenoflex bone and Ossix plus membrane for horizontal ridge augmentation. RCCS group: patients who received Ribose cross-linked collagen scaffold (Ossix Volumax) for horizontal ridge augmentation. Control group : patients who received dental implant placement without horizontal ridge augmentation. 4. Patients with age 20 year old and over

Exclusion criteria

Exclusion criteria: 1. Patients who have serious psychological disorder 2. Smoker and Alcoholism patients 3. Patients who unable to understand Thai language 4. Patients who reject to participate in this study 5. Patients who has systemic disease that affect to bone and soft tissue.

Design outcomes

Primary

MeasureTime frame
Bleeding on probing (BOP) 6 months after crown loading using a 0.5-mm. diameter periodontal probe by one examiner.,Probing pocket depth (PPD) 6 months after crown loading using a 0.5-mm. diameter periodontal probe by one examiner.,Plaque index (PI) 6 months after crown loading present or absence,Marginal bone level (MBL) 6 months after crown loading The instrument is an intraoral radiograph taken using a standard holder and the parallel technique at 2 different time point,Food impaction 6 months after crown loading Clinical and radiographic evaluations measured interproximal contact tightness, papilla fill, and tissue health. Likert scale will be used to assess the frequency of food impaction,Emergence angle 6 months after crown loading EA will be measurement by the parallel projection radiographic technique.

Secondary

MeasureTime frame
Oral Health Impact Profile (OHIP-14) 6 months after crown loading The Thai version of the Oral Health Impact Profile (OHIP-14) questionnaire will be utilized to measure oral health-related quality of life ,satisfaction questionnaire will be employed to assess overall patient satisfaction. 6 months after crown loading 3.7 The Thai version of the satisfaction questionnaire will be employed to assess overall patient satisfaction.

Countries

Thailand

Contacts

Public ContactKasira Kritsutthikun

Faculty of dentistry Chulalongkorn University

k.kasira59@gmail.com0629542651

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026